Effects of glucose limitation on biomass and spiramycin production by Streptomyces ambofaciens

Bioprocess and Biosystems Engineering
2005.0

Abstract

Spiramycin production by Streptomyces ambofaciens Sp181110 with glucose as the carbon source was studied under a controlled nutritional environment. In a batch culture, the glucose excess after ammonium depletion led to pyruvate and alpha-ketoglutarate accumulation. 85 mg/l of spiramycin were produced in less than 70 h during the stationary and maintenance phase on these acids after glucose exhaustion. Fed-batch strategy was designed to study spiramycin production without by-product formation and glucose accumulation. In these conditions, up to 150 mg/l were produced in less than 80 h during the stationary phase on glucose. The antibiotic titre was found independent of the glucose feeding under carbon limitation and the importance of putative intracellular reserves formed after nutrient exhaustion was suggested. Besides, spiramycin production was not inhibited by the limiting flux of glucose.

Knowledge Graph

Similar Paper

Effects of glucose limitation on biomass and spiramycin production by Streptomyces ambofaciens
Bioprocess and Biosystems Engineering 2005.0
Fermentative production of spiramycins
Enzyme and Microbial Technology 1982.0
Influence of short-chain fatty acids on the production of spiramycin by Streptomyces ambofaciens
Applied Microbiology and Biotechnology 1992.0
Selection of Streptomyces ambofaciens mutants that produce large quantities of spiramycin and determination of optimal conditions for spiramycin production
Applied and Environmental Microbiology 1990.0
Influence of dextrins on the production of spiramycin and impurity components by Streptomyces ambofaciens
Folia Microbiologica 2018.0
Effect of ammonium ions on spiramycin biosynthesis in Streptomyces ambofaciens
Applied Microbiology and Biotechnology 1992.0
Enhanced Natamycin production by Streptomyces natalensis in shake-flasks and stirred tank bioreactor under batch and fed-batch conditions
BMC Biotechnology 2019.0
Resistance to spiramycin in Streptomyces ambofaciens, the producer organism, involves at least two different mechanisms
Journal of General Microbiology 1993.0
Time-Resolved Transcriptomics and Constraint-Based Modeling Identify System-Level Metabolic Features and Overexpression Targets to Increase Spiramycin Production in Streptomyces ambofaciens
Frontiers in Microbiology 2017.0
Genetic and biochemical features of spiramycin biosynthesis in Streptomyces ambofaciens. Curing, protoplast regeneration and plasmid transfer.
The Journal of Antibiotics 1982.0